ROCHE DIABETES CARE LIMITED

09055599
Active Burgess Hill

Other business support service activities n.e.c.

34 employees website.com
Life sciences and medical technology Other business support service activities n.e.c.
R

ROCHE DIABETES CARE LIMITED

09055599

Other business support service activities n.e.c.

Founded 23 May 2014 Active Burgess Hill, United Kingdom 34 employees website.com
Life sciences and medical technology Other business support service activities n.e.c.

Previous Company Names

ROCHE DIABETES CARE (UK) LIMITED 23 May 2014 — 22 Jul 2014
Accounts Submitted 30 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 19 Jun 2025 Next due 25 Jun 2026 0 days remaining
Net assets £10M £1M 2024 year on year
Total assets £10M £4M 2024 year on year
Total Liabilities £0 £5M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Charles Avenue Burgess Hill RH15 9RY

Website

www.example.com

Full company profile for ROCHE DIABETES CARE LIMITED (09055599), an active life sciences and medical technology company based in Burgess Hill, United Kingdom. Incorporated 23 May 2014. Other business support service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

N/A

Decreased by £3.00k (-100%)

Net Assets

£10.44M

Increased by £1.23M (+13%)

Total Liabilities

N/A

Decreased by £5.46M (-100%)

Turnover

£21.36M

Decreased by £4.84M (-18%)

Employees

34

Decreased by 36 (-51%)

Debt Ratio

N/A

Decreased by 37 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 399,900 Shares £1279640.01m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
1 Oct 2014399,900£1279640.01m£3.20m

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Roche Holding (uk) Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

ROCHE DIABETES CARE LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
9 Apr 2026OfficersAppointment of Mr Allan Pamba as director on 1 Apr 2026
9 Apr 2026OfficersTermination of Geoffrey John Twist as director on 1 Apr 2026
14 Nov 2025OfficersAppointment of Mrs Kathryn Ryan Rowbotham as director on 2 Nov 2025
13 Nov 2025OfficersTermination of Richard William Erwin as director on 2 Nov 2025
13 Nov 2025OfficersTermination of Niklas Kruse as director on 1 Nov 2025
9 Apr 2026 Officers

Appointment of Mr Allan Pamba as director on 1 Apr 2026

9 Apr 2026 Officers

Termination of Geoffrey John Twist as director on 1 Apr 2026

14 Nov 2025 Officers

Appointment of Mrs Kathryn Ryan Rowbotham as director on 2 Nov 2025

13 Nov 2025 Officers

Termination of Richard William Erwin as director on 2 Nov 2025

13 Nov 2025 Officers

Termination of Niklas Kruse as director on 1 Nov 2025

Recent Activity

Latest Activity

Appointment of Mr Allan Pamba as director on 1 Apr 2026

2 months ago on 9 Apr 2026

Termination of Geoffrey John Twist as director on 1 Apr 2026

2 months ago on 9 Apr 2026

Appointment of Mrs Kathryn Ryan Rowbotham as director on 2 Nov 2025

7 months ago on 14 Nov 2025

Termination of Richard William Erwin as director on 2 Nov 2025

7 months ago on 13 Nov 2025

Termination of Niklas Kruse as director on 1 Nov 2025

7 months ago on 13 Nov 2025